Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

被引：6
|
作者：
Mambet, Cristina [1 ,2 ,3 ]
Babosova, Olga [4 ]
Defour, Jean-Philippe [2 ,5 ]
Leroy, Emilie [1 ,2 ]
Necula, Laura [3 ]
Stanca, Oana [6 ,7 ]
Tatic, Aurelia [7 ,8 ]
Berbec, Nicoleta [6 ,7 ]
Coriu, Daniel [7 ,8 ]
Belickova, Monika [9 ]
Kralova, Barbora [10 ]
Lanikova, Lucie [4 ]
Vesela, Jitka [9 ]
Pecquet, Christian [1 ,2 ]
Saussoy, Pascale [5 ]
Havelange, Violaine [11 ]
Diaconu, Carmen C. [3 ]
Divoky, Vladimir [10 ]
Constantinescu, Stefan N. [1 ,2 ,3 ]
机构：
[1] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium
[2] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium
[3] Stefan S Nicolau Inst Virol, Mol Profiling Myeloproliferat Neoplasms & Acute L, Bucharest, Romania
[4] Acad Sci Czech Republ, Inst Mol Genet, Dept Cell & Dev Biol, Prague, Czech Republic
[5] Catholic Univ Louvain, Clin Univ St Luc, Dept Biol Clin, Brussels, Belgium
[6] Coltea Clin Hosp, Dept Hematol, Bucharest, Romania
[7] Carol Davila Univ Med & Pharm, Dept Radiol Oncol & Hematol, Bucharest, Romania
[8] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania
[9] Inst Hematol & Blood Transfus, Prague, Czech Republic
[10] Palacky Univ, Fac Med & Dent, Dept Biol, Hnevotinska 3, CZ-77515 Olomouc, Czech Republic
[11] Clin Univ St Luc, Serv Hematol, Brussels, Belgium
来源：
BLOOD | 2018年 / 132卷 / 25期
关键词：
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA;
D O I：
10.1182/blood-2018-04-843060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2695 / 2699
页数：7
相关论文
共 50 条
  • [21] Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
    Hinds, David A.
    Barnholt, Kimberly E.
    Mesa, Ruben A.
    Kiefer, Amy K.
    Do, Chuong B.
    Eriksson, Nicholas
    Mountain, Joanna L.
    Francke, Uta
    Tung, Joyce Y.
    Nguyen, Huong
    Zhang, Haiyu
    Gojenola, Linda
    Zehnder, James L.
    Gotlib, Jason
    BLOOD, 2016, 128 (08) : 1121 - 1128
  • [22] Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
    Benati, Marco
    Montagnana, Martina
    Danese, Elisa
    De Matteis, Giovanna
    Veneri, Dino
    Paviati, Elisa
    Guidi, Gian Cesare
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (07) : 1005 - 1011
  • [23] JAK2 V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms
    Oyama, Naoki
    Iwamoto, Takanori
    Doyu, Keito
    Miyazato, Saki
    Okazaki, Tomoko
    Yamada, Seiko
    Kondo, Toshinori
    Wada, Hideho
    Yagita, Yoshiki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (12) : 1917 - 1926
  • [24] A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders
    Hamidah, N. H.
    Farisah, N. R.
    Azlinda, A. B.
    Wong, F. L.
    Das, S.
    Fadillah, S. A. W.
    Ainoon, O.
    CLINICA TERAPEUTICA, 2012, 163 (02): : 109 - 113
  • [25] Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders
    Sazawal, Sudha
    Bajaj, Jyoti
    Chikkara, Sunita
    Jain, Sonal
    Bhargava, Rahul
    Mahapatra, Manoranjan
    Saxena, Renu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (04) : 423 - 427
  • [26] Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR
    Waterhouse, Miguel
    Follo, Marie
    Pfeifer, Dietmar
    von Bubnoff, Nikolas
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 739 - 744
  • [27] Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis
    Yoo, E. -H.
    Jang, J. -H.
    Park, K. -J.
    Gwak, G. -Y.
    Kim, H. -J.
    Kim, S. -H.
    Kim, D. -K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (05) : 471 - 476
  • [28] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
    Kilpivaara, Outi
    Mukherjee, Semanti
    Schram, Alison M.
    Wadleigh, Martha
    Mullally, Ann
    Ebert, Benjamin L.
    Bass, Adam
    Marubayashi, Sachie
    Heguy, Adriana
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Offit, Kenneth
    Stone, Richard M.
    Gilliland, D. Gary
    Klein, Robert J.
    Levine, Ross L.
    NATURE GENETICS, 2009, 41 (04) : 455 - 459
  • [29] JAK2 mutations in myeloproliferative neoplasms: a 2008 update
    Guerin, Estelle
    Praloran, Vincent
    Lippert, Eric
    HEMATOLOGIE, 2008, 14 (05): : 368 - 377
  • [30] SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
    Koren-Michowitz, Maya
    Gery, Sigal
    Tabayashi, Takayuki
    Lin, Dechen
    Alvarez, Rocio
    Nagler, Arnon
    Koeffler, H. Phillip
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (06) : 811 - 820
12345